Date: 5/11/2021
May 11, 2021 (Burlington, MA) – LuMind IDSC Foundation today announced a new collaboration with Merck, known as MSD outside the United States and Canada, to initiate several sub-studies in the ongoing Longitudinal Investigation for the Enhancement of Down Syndrome Research (LIFE-DSR) cohort. LIFE-DSR is a longitudinal study of 270 adults with Down syndrome, their medical histories, blood samples, and neuropsychological testing data.

Date: 5/11/2021
May 11, 2021 (Burlington, MA) – LuMind IDSC Foundation today announced a new collaboration with Merck, known as MSD outside the United States and Canada, to initiate several sub-studies in the ongoing Longitudinal Investigation for the Enhancement of Down Syndrome Research (LIFE-DSR) cohort. LIFE-DSR is a longitudinal study of 270 adults with Down syndrome, their medical histories, blood samples, and neuropsychological testing data.

Date: 4/30/2021
Today the LuMind IDSC Foundation, a leading national Down syndrome research and advocacy organization, announced the establishment of the LuMind IDSC Research Consortium to accelerate research into critical medical issues impacting people with Down syndrome. AbbVie and Merck, known as MSD outside the United States and Canada, are the first members of the LuMind IDSC Research Consortium, an association which is modeled on a previous collaboration between LuMind IDSC and Eli Lilly and Company.

Date: 4/30/2021
Today the LuMind IDSC Foundation, a leading national Down syndrome research and advocacy organization, announced the establishment of the LuMind IDSC Research Consortium to accelerate research into critical medical issues impacting people with Down syndrome. AbbVie and Merck, known as MSD outside the United States and Canada, are the first members of the LuMind IDSC Research Consortium, an association which is modeled on a previous collaboration between LuMind IDSC and Eli Lilly and Company.

Date: 4/19/2021
This week, the Down syndrome community is celebrating the release of an article in the journal: Translational Science of Rare Diseases. Led by LuMind IDSC’s Chief Science Officer, James Hendrix, an international team of Down syndrome experts has charted a unified path toward a new future for Down syndrome research with the article: “Opportunities, barriers, and recommendations in down syndrome research.”

Date: 4/19/2021
This week, the Down syndrome community is celebrating the release of an article in the journal: Translational Science of Rare Diseases. Led by LuMind IDSC’s Chief Science Officer, James Hendrix, an international team of Down syndrome experts has charted a unified path toward a new future for Down syndrome research with the article: “Opportunities, barriers, and recommendations in down syndrome research.”

Date: 3/2/2021
Today, an important and timely COVID-19 and Down Syndrome Resource (“Resource”) was published by a consortium of national Down syndrome organizations: the Down Syndrome Medical Interest Group-USA (DSMIG-USA), Global Down Syndrome Foundation (GLOBAL), LuMind IDSC Foundation (LuMind IDSC), National Down Syndrome Congress (NDSC), National Down Syndrome Society (NDSS), and National Task Group on Intellectual Disabilities and Dementia Practices (NTG).

Date: 3/2/2021
Today, an important and timely COVID-19 and Down Syndrome Resource (“Resource”) was published by a consortium of national Down syndrome organizations: the Down Syndrome Medical Interest Group-USA (DSMIG-USA), Global Down Syndrome Foundation (GLOBAL), LuMind IDSC Foundation (LuMind IDSC), National Down Syndrome Congress (NDSC), National Down Syndrome Society (NDSS), and National Task Group on Intellectual Disabilities and Dementia Practices (NTG).

Date: 12/15/2020
The Alana Down Syndrome Center (ADSC) at MIT hosted the New England Down Syndrome Symposium on November 10, 2020 in collaboration with the Massachusetts Down Syndrome Congress (MDSC) and Lumind IDSC Foundation (LuMind IDSC).

Date: 12/15/2020
The Alana Down Syndrome Center (ADSC) at MIT hosted the New England Down Syndrome Symposium on November 10, 2020 in collaboration with the Massachusetts Down Syndrome Congress (MDSC) and Lumind IDSC Foundation (LuMind IDSC).